Has Marlboro hijacked tobacco harm reduction?

Addiction

Volumn 107, Issue 6, 2012, Pages 1029-1030

  Gray, Nigel ^a  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Harm reduction; Philip Morris; Smokeless tobacco; Snus

Indexed keywords

NITROSAMINE;

ADVERTIZING; CHEMISTRY; EDITORIAL; ETHICS; HARM REDUCTION; HUMAN; SMOKELESS TOBACCO; TOBACCO INDUSTRY;

ADVERTISING AS TOPIC; HARM REDUCTION; HUMANS; NITROSAMINES; TOBACCO INDUSTRY; TOBACCO, SMOKELESS;

EID: 84860582893     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03748.x     Document Type: Editorial

References (5)

1. International Agency for Research on Cancer. Smokeless Tobacco and Tobacco-Related Nitrosamines [89], 444-453. Lyon: IARC Press; 2005.
2. Boffetta P., Hecht S., Gray N., Gupta P., Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008; 9: 667-75.
3. Gray N., Zaridze D., Robertson C., Krivosheeva L., Sigacheva N., Boyle P. Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study. Tob Control 2000; 9: 351.
4. Hatsukami D. K., Ebbert J. O., Feuer R. M., Stepanov I., Hecht S. S. Changing smokeless tobacco products new tobacco-delivery systems. Am J Prev Med 2007; 33: S368-78.
5. Borland R., Fagerström K., Foulds J., MacNeill A., Ramström L. FCTC background report on smokeless tobacco is incompatible with WHO scientific reports. Addiction 2011; 106: 225-7.